New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Avalon Rare Metals Inc (US listing) (NYSEMKT:AVL), Renren Inc (NYSE:RENN), Immunomedics, Inc (NASDAQ:IMMU), China Finance Online Co. (ADR) (NASDAQ:JRJC)
Avalon Rare Metals Inc (US listing) (NYSEMKT:AVL) showed a volume of 1.71million shares by the end of last trade whereas the average volume of the stock remained 623,862.00 shares. The stock opened the session at $0.57 but then moved to $0.586. At that price, the stock showed a positive performance of 6.45%. Avalon Rare Metals Inc. (Avalon) is a Canada-based mineral exploration and development company. The Company’s primary focus is on rare metals and minerals, including tin, lithium, tantalum, niobium, cesium, indium, gallium, zirconium and calcium feldspar. It is in the process of exploring or developing three of its six mineral resource properties.
Will AVL Continue To Move Higher? Find Out Here
Renren Inc (NYSE:RENN) opened the session at $3.03 and closed the session at $3.17. The stock showed a positive performance of 3.93% in previous trading session. Traded with volume of 1.69 million shares in the prior session and the average volume of the stock remained 2.09 million shares. Renren Inc. operates real name social networking Internet platform in the People’s Republic of China. Its platform enables its users to connect and communicate with each other, share information and user-generated content, play online games, listen to music, shop for deals and a range of other features and services.
For How Long RENN will fight for Profitability? Read This Trend Analysis report
Immunomedics, Inc (NASDAQ:IMMU) opened the session at $4.75 and closed the session at $4.91. The stock showed a positive performance of 4.91% in previous trading session. Traded with volume of 1.67 million shares in the prior session and the average volume of the stock remained 880,740.00 shares. The beta of the stock remained 1.91. Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics,
Why Should Investors Buy IMMU After The Recent Gain? Just Go Here and Find Out
China Finance Online Co. (ADR) (NASDAQ:JRJC) the stock decreased -12.08% and finished the session at $5.53. Traded with volume of 1.70 million shares in the prior session and the average volume of the stock remained 407,431.00 shares. The beta of the stock remained 1.28. China Finance Online Co. Limited (CFO Hong Kong) is a provider of vertically integrated financial services, including news, data, analytics and brokerage through Web portals, software systems and mobile handsets. The Company has two principal operating segments: online financial data subscription service and other related services, and brokerage service.
Will JRJC Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)